Reports

The global HLA-Homozygous iPSC Cell Bank market was valued at 58.44 million in 2025 and is projected to reach US$ 307 million by 2032, at a CAGR of 26.5% during the forecast period.

The global GMP-Grade iPSC Master Cell Bank market was valued at 260 million in 2025 and is projected to reach US$ 769 million by 2032, at a CAGR of 16.9% during the forecast period.

The global Robotic Radiotherapy market was valued at 817 million in 2025 and is projected to reach US$ 1601 million by 2032, at a CAGR of 10.2% during the forecast period.

The global Single-stranded AAV Vector Packaging Service market was valued at 537 million in 2025 and is projected to reach US$ 1528 million by 2032, at a CAGR of 16.4% during the forecast period.

The global CAR-NK Cell Therapy market was valued at 2163 million in 2025 and is projected to reach US$ 3258 million by 2032, at a CAGR of 6.2% during the forecast period.

The global Tumor Organoid Drug Screening Platform market was valued at 333 million in 2025 and is projected to reach US$ 1196 million by 2032, at a CAGR of 20.0% during the forecast period.

The global T Cell Persistence Engineering Platform market was valued at 566 million in 2025 and is projected to reach US$ 1954 million by 2032, at a CAGR of 19.5% during the forecast period.

The global Adeno-Associated Virus (AAV) Packaging Service market was valued at 1141 million in 2025 and is projected to reach US$ 2521 million by 2032, at a CAGR of 12.0% during the forecast period.

The global Genomic Stability Testing Services market was valued at 475 million in 2025 and is projected to reach US$ 1552 million by 2032, at a CAGR of 18.6% during the forecast period.

The global Gene-Edited Donor Animal Breeding System market was valued at 115 million in 2025 and is projected to reach US$ 636 million by 2032, at a CAGR of 28.0% during the forecast period.